Search - tctmd.com

Displaying 41 - 60 of 82

Sort: Relevancy | Date

Presentation Controversies and Advances 2019

Echo imaging in HFpEF

Presenter: Jeroen Bax

November 15, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Industry News

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

June 24, 2019

News Conference News TVT 2019

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Michael O'Riordan

June 17, 2019

News Conference News TVT 2019

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

Shelley Wood

June 17, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Features

Top News in Structural Heart Disease: 2018

L.A. McKeown

December 28, 2018

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation ECHO 2018

Infiltrative and Restrictive Cardiomyopathy: Recognition by Echo

Presenter: Gerard P. Aurigemma

April 19, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

Shelley Wood

March 01, 2018

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Daily News

Conscious Sedation in TAVR Cuts Costs by 25%, Boosts Patient Satisfaction

Shelley Wood

April 13, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

Shelley Wood

March 17, 2017

News Daily News

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Todd Neale

February 06, 2017

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

Presentation TVT 2016

AS and the Patient With Hypertrophic Cardiomyopathy (With and Without Obstruction)

Presenter: Chet Rihal

June 17, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Todd Neale

May 16, 2016

Advertisement

Echo imaging in HFpEF

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation

Faster and Larger Gains in Physical Function With TAVR Than With Surgery: SURTAVI

Transcarotid Bests Aortic/Apical for Alternative TAVR Access: TVT Registry

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Top News in Structural Heart Disease: 2018

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

High Mortality but Durable Results With Valve-in-Valve TAVR

Infiltrative and Restrictive Cardiomyopathy: Recognition by Echo

TCTMD’s Top 10 Most Popular Stories for February 2018

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Conscious Sedation in TAVR Cuts Costs by 25%, Boosts Patient Satisfaction

Live From Washington: ACC 2017, Day One

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

AS and the Patient With Hypertrophic Cardiomyopathy (With and Without Obstruction)

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content